Mon, March 9, 2020
Sun, March 8, 2020
Fri, March 6, 2020
Thu, March 5, 2020

Andrew Fein Reiterated (SYRS) at Hold with Decreased Target to $80 on, Mar 6th, 2020

Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Hold with Decreased Target from $100 to $80 on, Mar 6th, 2020.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Nierengarten of "Wedbush" Downgraded from Buy to Hold and Held Target at $90 on, Friday, January 17th, 2020